Insights on the High Potency Active Pharmaceutical Ingredients (HPAPI) Market to 2027 | Industry Statistics, Emerging Demands, Forecast to 2027
The global high potency active pharmaceutical ingredients (HPAPI) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). High potent active pharmaceutical ingredients (HPAPIs) are pharmacologically active substances. They exhibit biological activity at extremely low concentrations such as a daily therapeutic dose of <10 mg or an occupational exposure limit (OEL) of < 10 µg/m3 at an eight-hour time-weighted average. The major factor driving the demand for high potency active pharmaceutical ingredients (HPAPI) is the increasing prevalence of cancer. These drugs play an important role to treat many diseases such as cancer. Additionally, the increasing focus of pharmaceutical companies on the development of potent compounds will create ample growth opportunities for the market during the forecast period. However, the growth of the market is hampered due to the high cost involved in transporting and managing HPAPIs.
To Request a Sample of our Report on High Potency Active
Pharmaceutical Ingredients (HPAPI) Market: https://www.omrglobal.com/request-sample/high-potency-active-pharmaceutical-ingredients-hpapi-market
Some major players in the market include Novartis
International AG, Pfizer Inc., and Sanofi SA, among others. The market players
are contributing significantly to the growth of the market by the adoption of
various strategies including mergers & acquisitions, geographical
expansion, partnerships and collaborations, and new product launches, to stay
competitive in the market. For instance, in September 2020, Sequens Group announced
the opening of a production unit in Villeneuve-La-Garenne, France. The unit was
based on the product of a high potency active pharmaceutical.
Market Coverage
•
The market number available for – 2020-2027
•
Base year- 2020
•
Forecast period- 2021-2027
Segment Covered-
•
By Type
•
By Application
Regions Covered-
•
North America
•
Europe
•
Asia-Pacific
•
Rest of the World
Competitive Landscape- Novartis
International AG, Pfizer Inc., and Sanofi SA, among others.
(Get 15% Discount on Buying this Report)
A
full Report of High Potency Active Pharmaceutical Ingredients (HPAPI) Market is
Available @ https://www.omrglobal.com/industry-reports/high-potency-active-pharmaceutical-ingredients-hpapi-market
Global High Potency Active Pharmaceutical Ingredients
(HPAPI) Market Report by Segment
By Type
•
Branded HPAPI
•
Generic HPAPI
By Application
•
Oncology
•
Glaucoma
•
Hormonal Disorder
•
Others
Global High Potency Active Pharmaceutical Ingredients
(HPAPI) Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment